Home » Stocks » RKDA

Arcadia Biosciences, Inc. (RKDA)

Stock Price: $3.24 USD 0.07 (2.21%)
Updated Mar 1, 2021 4:00 PM EST - Market closed
Market Cap 69.53M
Revenue (ttm) 1.32M
Net Income (ttm) -19.80M
Shares Out 10.72M
EPS (ttm) -2.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 1
Last Price $3.24
Previous Close $3.17
Change ($) 0.07
Change (%) 2.21%
Day's Open 3.19
Day's Range 3.17 - 3.33
Day's Volume 407,117
52-Week Range 2.30 - 6.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Proactive Investors - 5 days ago

Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) shares rose Wednesday as the agricultural biotech group said it had boosted its board with Debbie Carosella, a food industry executive and forme...

PRNewsWire - 5 days ago

DAVIS, Calif., Feb. 24, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food in...

PRNewsWire - 2 months ago

DAVIS, Calif., Dec. 22, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food in...

PRNewsWire - 2 months ago

DAVIS, Calif., Dec. 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food in...

Seeking Alpha - 3 months ago

RKDA has had a number of important developments which I review here. They include: A transformative transaction in the HB4 soybean space.

Seeking Alpha - 3 months ago

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 3 months ago

DAVIS, Calif., Nov. 12, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA) today announced a series of strategic transactions with Bioceres Crop Solutions Corp (NYSE: BIOX), includi...

Other stocks mentioned: BIOX
Seeking Alpha - 6 months ago

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 6 months ago

DAVIS, Calif., Aug. 13, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.

PRNewsWire - 7 months ago

DAVIS, Calif., July 30, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.

Seeking Alpha - 7 months ago

Chinese Approval Of HB4 Soybeans Could Be A Major Catalyst For Arcadia Biosciences

PRNewsWire - 7 months ago

DAVIS, Calif., July 6, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ing...

Seeking Alpha - 8 months ago

Arcadia Biosciences: An Update On Its Hemp/CBD Operations

PRNewsWire - 9 months ago

DAVIS, Calif., May 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ing...

Seeking Alpha - 9 months ago

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 11 months ago

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q4 2019 Results - Earnings Call Transcript

Benzinga - 1 year ago

Arcadia Biosciences Inc (NASDAQ: RKDA), a developer of food ingredients and nutritional oils, with some pre-existing hemp assets and a partnership with Shane Victorino, a former MLB player and...

Seeking Alpha - 1 year ago

I'm Joining Insiders In Buying Arcadia Biosciences Stock

Seeking Alpha - 1 year ago

Arcadia Biosciences, Inc. (RKDA) CEO Matt Plavan on Q3 2019 Results - Earnings Call Transcript

Benzinga - 1 year ago

Arcadia Biosciences, Inc. (NASDAQ: RKDA) reported third-quarter revenue of $392,000 on Wednesday, an increase from revenue of $370,000 in the same quarter in 2018.

Seeking Alpha - 1 year ago

Preview Of Q3 For Arcadia Biosciences

Benzinga - 1 year ago

Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures.

Seeking Alpha - 1 year ago

USDA approval of soybean could be a major catalyst longer term for RKDA, potentially generating up to $125M in annual revenues at 60%+ margins.

Benzinga - 1 year ago

Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA), announced this week plans for a new sun-grown hemp cultivation and ...

Market Watch - 1 year ago

Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, r...

Benzinga - 1 year ago

Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Mil...

Seeking Alpha - 1 year ago

Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q2 2019 Results - Earnings Call Transcript

Benzinga - 1 year ago

Arcadia Biosciences (NASDAQ: RKDA) is expected to announce Tuesday a joint venture with Legacy Ventures Hawaii to grow, extract and sell superior hemp products, Benzinga has learned exclusively.

Zacks Investment Research - 1 year ago

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for th...

Seeking Alpha - 1 year ago

Arcadia Biosciences' (RKDA) CEO Rajendra Ketkar on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q4 2018 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

In July of last year I explained why I wanted to have exposure to the agricultural genome-editing space, and after examining a few pure plays, I then went on to describe why Arcadia Bioscience...

CNBC Television - 2 years ago

Final trades: Aptiv, Alphabet, Ross Stores, Abbvie, Acadia Healthcare & this silver ETF

The "Halftime Report" traders give their top stocks to watch for the second half.

Other stocks mentioned: ABBV, APTV, GOOGL, ROST, XLV

About RKDA

Arcadia Biosciences, a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools foc... [Read more...]

Industry
Agricultural Inputs
IPO Date
May 15, 2015
CEO
Matthew T. Plavan
Employees
41
Stock Exchange
NASDAQ
Ticker Symbol
RKDA
Full Company Profile

Financial Performance

In 2019, RKDA's revenue was $1.17 million, a decrease of -20.15% compared to the previous year's $1.46 million. Losses were -$28.81 million, 113.7% more than in 2018.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for RKDA stock is "Buy." The 12-month stock price forecast is 6.52, which is an increase of 101.23% from the latest price.

Price Target
$6.52
(101.23% upside)
Analyst Consensus: Buy